For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
This week in health care policy: October 31-November 6, 2026
Drug pricing and PBMs Medicare’s second round of negotiated prices starts in two months. On January 1, negotiated prices for…
Blog
This week in health care policy: October 24-30, 2026
FDA and innovation FDA and CMS move on personalized gene therapies. The FDA released draft guidance that lets developers of…
Blog
Market-oriented reforms that can save Medicare $100 billion
Since 1970, Medicare spending has grown from 0.7 percent of GDP to 4.0 percent of GDP, and it is projected to grow even further.
Search Posts
News Release
FDA Investigates Benefits, Dangers of Eating Fish
FDA Investigates Benefits, Dangers of Eating Fish “Consumers Should Not Be Scared Away from Health Benefits of Fish” Washington, D.C., April 21, 2009—The Competitive…
News Release
VIDEO: People Make Earth Day Better
This year, the Competitive Enterprise Institute urges those celebrating Earth Day to remember the challenges presented by living in the natural world, and the inspiring ways that human…
Tulsa Business
Latest Study, Again, Shows Small Car Safety Risk
Tulsa Business
Food Safety Law and Small Producers, Cont’d
Newsletter
Somali Pirates, GM Executives and FDA Regulators
The U.S. military considers attacking Somali pirate bases. Treasury officials instruct General Motors to plan for bankruptcy. The Food and Drug Administration reconsiders its ban…
Blog
Jack Dreyfus, FDA Reform Pioneer
My colleague John Berlau wrote a nice obituary of mutual fund pioneer Jack Dreyfus that was published in Investor’s Business Daily earlier this week.